
The Invesco RAFI Strategic US ETF (the Fund) is designed to mirror the investment outcomes of the Invesco Strategic US Index (the Index). Typically, the Fund allocates at least 80% of its total assets to the securities that constitute this Index. The Index itself is constructed to measure the performance of prominent, high-quality American corporations. Securities are initially assigned a "Business-Size" score, which is an equally-weighted average of their sales, operating cash flow, total return of capital, and book value, calculated over the preceding five years or since the security's…
Is IUS's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.


Invesco RAFI Strategic US ETF is rated a Buy for value-oriented investors seeking balanced exposure amid market concentration and high valuations. IUS's methodology blends business fundamentals with a quality screen, holding market leaders like MSFT, NVDA, AMZN, GOOGL, and META in measured allocations. IUS offers lower concentration (top 10: 27.73%) and valuation (P/E: 18.83) than SPY, while outperforming VTV and MFUS on risk-adjusted returns since inception.

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced the MIUD

Berkeley Inc lifted its position in Invesco RAFI Strategic US ETF (NASDAQ: IUS) by 38.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 160,885 shares of the company's stock after buying an additional 44,479 shares during the period. Invesco

Invesco RAFI Strategic US ETF offers a 544-stock portfolio blending fundamental size and quality factors. IUS has a more balanced sector allocation than the S&P 500, underweighting technology and financials while maintaining large-cap predominance. IUS has outperformed both the S&P 500 and peer large value ETFs since 2018, making it a compelling long-term core holding alternative to cap-weighted funds.